Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 29, 2000

View Archived Issues

GeneMedix Moves Into Singapore To Capture Asian Protein Market

Wilex Raises EUR30M To Push Cancer Drugs Through Trials

Noxxon Brings In EUR20M For Spiegelmer Technology

Rademacher Raises #8.6 Million To Push Lead Projects Forward

European Pharma Association Launches Biotechnology Unit

BioTissue Taking Technology Public On Market In Germany

Finance, Science Come Together At Third Forum In Cambridge

CellFactors Gets Seed Funding To Develop Cell-Based Therapies

Syngenta Won't Plant GM Corn Despite OK From French Council

Glycominds Unveils Encoding Language, Launches Database

NeuroSearch, Organon Target GABA Receptors In Collaboration

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...